Skip to main content

The immune paradox of fondaparinux

Publication ,  Journal Article
Arepally, GM
Published in: Blood
December 1, 2005

In this issue of Blood, Warkentin and colleagues demonstrate that fondaparinux elicits an immune response to PF4/heparin. Antibodies induced by the drug do not recognize complexes of PF4/fondaparinux but, paradoxically, bind complexes of PF4/heparin and PF4/LMWH.

Duke Scholars

Published In

Blood

DOI

EISSN

0006-4971

ISSN

0006-4971

Publication Date

December 1, 2005

Volume

106

Issue

12

Start / End Page

3686 / 3687

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Arepally, G. M. (2005). The immune paradox of fondaparinux. Blood, 106(12), 3686–3687. https://doi.org/10.1182/blood-2005-09-3711
Arepally, G. M. “The immune paradox of fondaparinux.” Blood 106, no. 12 (December 1, 2005): 3686–87. https://doi.org/10.1182/blood-2005-09-3711.
Arepally GM. The immune paradox of fondaparinux. Blood. 2005 Dec 1;106(12):3686–7.
Arepally, G. M. “The immune paradox of fondaparinux.” Blood, vol. 106, no. 12, Dec. 2005, pp. 3686–87. Scopus, doi:10.1182/blood-2005-09-3711.
Arepally GM. The immune paradox of fondaparinux. Blood. 2005 Dec 1;106(12):3686–3687.

Published In

Blood

DOI

EISSN

0006-4971

ISSN

0006-4971

Publication Date

December 1, 2005

Volume

106

Issue

12

Start / End Page

3686 / 3687

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology